Could Renin-Angiotensin System Inhibitors Be Protective From Severe COVID-19?

Hypertension. 2021 Mar 3;77(3):843-845. doi: 10.1161/HYPERTENSIONAHA.120.16800. Epub 2021 Feb 10.

Author

Robert M Carey¹

Affiliation

¹ From the Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angiotensin Receptor Antagonists / pharmacology
Antihypertensive Agents* / pharmacology
Antihypertensive Agents* / therapeutic use
COVID-19*
Cohort Studies
Humans
Renin-Angiotensin System / drug effects
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Antihypertensive Agents